Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Artikel: DFG Deutsche Nationallizenzen  (1)
  • 1985-1989  (1)
  • 1905-1909
  • Alpha2 adrenoceptors  (1)
Datenquelle
  • Artikel: DFG Deutsche Nationallizenzen  (1)
Materialart
Erscheinungszeitraum
  • 1985-1989  (1)
  • 1905-1909
Jahr
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 335 (1987), S. 274-277 
    ISSN: 1432-1912
    Schlagwort(e): Alpha1 adrenoceptors ; Alpha2 adrenoceptors ; Arterial pressure ; Nucleus tractus solitarii
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary The cardiovascular effects of selective alpha1 and alpha2 agonists and antagonists injected into the nucleus tractus solitarii (NTS) were studied in urethane-anesthetized rats. Methoxamine (0.3–3 μg) injected bilaterally into the NTS caused a dose-dependent increase in blood pressure and heart rate. Phenylephrine (6 μg) and an imidazolidine derivative St 587 (3 μg) similarly injected also produced an increase in blood pressure, whereas a-methylnoradrenaline and an azepine derivative B-HT 920 (1 and 3 μg) caused a decrease in blood pressure and heart rate. The pressor response to methoxamine (1 μg) was markedly inhibited by prazosin (0.3 pg) injected into the same sites or hexamethionum (25 mg/kg, i. v.). Prazosin (0.3 μg) alone injected bilaterally into the NTS did not affect the blood pressure, while yohimbine (0.1 μg) similarly injected increased the pressure. These results suggest that in the rat NTS there exist alpha1 adrenoceptors responsible for an increase in arterial pressure. The NTS alpha2 adrenoceptors seem to be involved in the tonic regulation of arterial pressure.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...